[Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].
Reina J; Viana-Ramirez J
Abstract:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia:
2024
doi: 10.37201/req/049.2024
https://pubmed.ncbi.nlm.nih.gov/39010814
Related
